
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title |
Status![]() |
---|---|---|---|---|---|---|---|
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
2019 | R33 | CA225549 | RFA-CA-18-003 | TAVANA, HOSSEIN | UNIVERSITY OF AKRON | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | Active |
2018 | R33 | CA228979 | RFA-CA-17-011 | SCHRUM, ADAM G | UNIVERSITY OF MISSOURI-COLUMBIA | Multiplex matrix ELISA for T cell protein-interaction networks in cancer | Active |
2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
2020 | R21 | CA246457 | RFA-CA-19-019 | HATTORI, TAKAMITSU | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications | Active |
2019 | R33 | CA229042 | RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells | Active |
2018 | R33 | CA229023 | RFA-CA-17-011 | TEWARI, MUNEESH (contact); WALTER, NILS G | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations | Active |
2022 | R21 | CA272014 | CA21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |
2020 | R33 | CA236670 | RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH | Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways | Active |
2019 | R33 | CA229068 | RFA-CA-18-003 | SCHIAVINATO EBERLIN, LIVIA | UNIVERSITY OF TEXAS, AUSTIN | Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation | Active |
2018 | R21 | CA229037 | RFA-CA-17-012 | GULLEY, MARGARET L | UNIV OF NORTH CAROLINA CHAPEL HILL | EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing | Active |
2022 | R21 | CA272014 | CA21-003 | NABA, ALEXANDRA | UNIVERSITY OF ILLINOIS AT CHICAGO | Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2019 | R33 | CA235254 | RFA-CA-18-003 | FIOLKA, RETO PAUL | UT SOUTHWESTERN MEDICAL CENTER | Multiscale microscope for 3D cancer imaging in model organisms and organoids | Active |
2022 | R21 | CA267245 | CA21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2019 | R33 | CA235302 | RFA-CA-18-003 | DE VLAMINCK, IWIJN | CORNELL UNIVERSITY | Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer | Active |
2022 | R33 | CA267219 | CA21-004 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV | Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes | Active |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
2019 | R33 | CA235319 | RFA-CA-18-003 | YANG, JENNY J. | GEORGIA STATE UNIVERSITY | Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment | Active |
2018 | R33 | CA217702 | RFA-CA-17-013 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity | Active |
2022 | R33 | CA272321 | CA21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2020 | R43 | CA250885 | PAR-18-303 | REDER, NICHOLAS | LIGHTSPEED MICROSCOPY, INC. | Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies | Active |
2019 | R33 | CA235597 | RFA-CA-18-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia | Active |
2022 | R33 | CA259451 | CA21-004 | NAEGLE, KRISTEN M | UNIVERSITY OF VIRGINIA | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides | Active |
2020 | R21 | CA251052 | RFA-CA-19-019 | SHVETS, GENNADY | CORNELL UNIVERSITY | Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces | Active |
2019 | R33 | CA236687 | RFA-CA-18-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER | GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models | Active |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
2022 | R21 | CA272326 | CA21-003 | KELLY, RYAN T | BRIGHAM YOUNG UNIVERSITY | In-depth and label-free proteome profiling of hundreds of single cells per day | Active |
2020 | R21 | CA225493 | RFA-CA-19-019 | TEWARI, MUNEESH | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers | Active |
2019 | R33 | CA240201 | RFA-CA-18-003 | VAN DAM, ROBERT MICHAEL | UNIVERSITY OF CALIFORNIA LOS ANGELES | Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research | Active |
2022 | R21 | CA261643 | CA21-005 | TANG, SINDY KAM-YAN | STANFORD UNIVERSITY | A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy | Active |
2020 | R33 | CA251037 | RFA-CA-19-020 | WANG, SIYUAN | YALE UNIVERSITY | Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer | Active |
2019 | R21 | CA236652 | RFA-CA-18-004 | SINGAMANENI, SRIKANTH | WASHINGTON UNIVERSITY | METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION | Active |
2022 | R21 | CA272345 | CA21-003 | KNOWLES, DAVID ARTHUR | NEW YORK GENOME CENTER | A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | Active |
2018 | R21 | CA229044 | RFA-CA-17-010 | ABBOTT, KAREN L | UNIV OF ARKANSAS FOR MED SCIS | Novel platform linking cancer-specific glycosylation with cell signaling outcomes | Active |
2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
2019 | R21 | CA240219 | RFA-CA-18-004 | ANDRES-MARTIN, LAURA | NEW YORK STEM CELL FOUNDATION | Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections | Active |
2022 | R21 | CA272351 | CA21-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | Active |
2018 | R21 | CA223901 | RFA-CA-17-010 | BRENT, ROGER | FRED HUTCHINSON CANCER RESEARCH CENTER | Precision controllers of mammalian gene expression | Active |
2020 | R33 | CA236681 | RFA-CA-19-020 | WEI, CHIA-LIN | JACKSON LABORATORY | Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer | Active |
2019 | R33 | CA235326 | RFA-CA-18-005 | LEI, YUGUO | UNIVERSITY OF NEBRASKA LINCOLN | A Single Conical Tube Device for Precision CAR-T Cells Manufacturing | Active |
2022 | R33 | CA272357 | CA21-004 | PAN, TAO | UNIVERSITY OF CHICAGO | Transfer RNA sequencing and application to cancer research and clinics | Active |
2022 | R33 | CA267258 | CA21-004 | LEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy | Active |
2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Active |
2020 | R21 | CA229024 | RFA-CA-19-019 | HUR, SOOJUNG CLAIRE | JOHNS HOPKINS UNIVERSITY | Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy | Active |
2022 | R21 | CA267012 | CA21-003 | SNYDER, JOSHUA CLAIR | DUKE UNIVERSITY | Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color | Active |
2020 | R33 | CA246448 | RFA-CA-19-020 | HALL, ADAM ROGER | WAKE FOREST UNIVERSITY HEALTH SCIENCES | Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores | Active |
2020 | R21 | CA236612 | RFA-CA-19-019 | REVZIN, ALEXANDER | MAYO CLINIC ROCHESTER | A microfluidic cell culture platform for personalizing pancreatic cancer therapies | Active |
2019 | R21 | CA217662 | RFA-CA-18-002 | IM, HYUNGSOON | MASSACHUSETTS GENERAL HOSPITAL | Nano-plasmonic technology for high-throughput single exosome analyses | Active |